SC Filed 2023-10-04 Event — SEC 0001140361-23-046991 →

Roivant Sciences Ltd. → Immunovant, Inc. IMVT

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

2 13D/G filings on this issuer

1 other filing besides this one

Filer Track Record

10 filings by this filer

9 other filings in the data moat

Short Interest · settle 2026-03-31

DTC 12.36

18,430,920 shares short · +11.3% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $50.84M

Point72 Asset Mgmt

Other 13D/G Filings on Immunovant, Inc.

Filed	Form	Filer	Stake	Shares
2025-01-15	SCHEDULE	Roivant Sciences Ltd.	56.90%	96,660,341	view →

Other Filings by Roivant Sciences Ltd.

Filed	Form	Issuer	Stake	Shares
2025-02-25	SCHEDULE	Arbutus Biopharma Corp ABUS	20.50%	38,847,462	view →
2025-02-18	SCHEDULE	Arbutus Biopharma Corp ABUS	20.50%	38,847,462	view →
2025-01-15	SCHEDULE	Immunovant, Inc. IMVT	56.90%	96,660,341	view →
2021-10-20	SC	Arbutus Biopharma Corp ABUS	—	—	view →
2018-04-23	SC	Arbutus Biopharma Corp ABUS	—	—	view →
2018-04-12	SC	Arbutus Biopharma Corp ABUS	—	—	view →
2018-03-16	SC	Arbutus Biopharma Corp ABUS	—	—	view →
2018-02-14	SC	Arbutus Biopharma Corp ABUS	—	—	view →
2018-01-16	SC	Arbutus Biopharma Corp ABUS	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →